Company: BLUWU
Filing Date: 2025-06-05
Form Type: CORRESP
Source: 0001641172-25-013836
Chunk: 0

Company: Blue Water Acquisition Corp. III
Filing Date: 2025-06-05
Form: CORRESP
Chunk 0
---
| Andrei         
 Sirabionian    
 Partner        
 345            
 Park Avenue    
 New            
 York, NY 10154 | Direct          212.407.4089 
 Main                         
 212.407.4000                 
 Fax                          
 212.937.4990                 
 asirabionian@loeb.com        |

June 5, 2025

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Real Estate and Construction

100 F Street, NE

Washington, DC 20549

| Re: | Blue                                        
 Water Acquisition Corp. III                 
 Amendment                                   
 No. 2 to Registration Statement on Form S-1 
 Filed                                       
 May 23, 2025                                |
|:----|:--------------------------------------------|
|     | File                                        
 No. 333-285075                              |

Ladies and Gentlemen:

On behalf of our client, Blue Water Acquisition Corp. III (the “ Company”), we are writing to submit responses to the comments of the staff (the “ Staff”) of the Division of Corporation Finance of the United States Securities and Exchange Commission (the “ Commission”) set forth in its letter dated June 5, 2025, relating to the above-referenced Registration Statement on Form S-1.

The Company is filing via EDGAR Amendment No. 3 to Registration Statement on Form S-1 (the “ Amended Registration Statement”), which reflects responses to the comments received by the Staff and certain updated information.

We have set forth below the comments in the Staff’s letter, in bold, and the responses thereto. All page references in the responses set forth below refer to the page numbers in the Amended Registration Statement.

Amendment No. 2 to Registration Statement on Form S-1

Part II. Information not required in prospectus

Item 16. Exhibits and Financial Statement Schedules

Exhibit 5.2, page II-2

| 1. | We                                                                                                                                     
 note that assumption 2.10 in Exhibit 5.2, assumes the due authorization and execution of all documents. This assumption appears overly 
 broad as it relates to the company. Please have counsel revise the opinion as appropriate to exclude the company from this assumption. 
 Refer to Section II.B.3.a of Staff Legal Bulletin No. 19.                                                                              |

Response:In response to the Staff’s comment, the Company is filing the revised Exhibit 5.2 removing assumption 2.10.

If you have any